Form 4 holding
CEO, Director
ACADIA PHARMACEUTICALS INC
- Security class
- Common Stock
- Shares / value
- 186,555
- Estimated value
- $2,850,560
- Report date
- 19 Aug 2024
- Price
- $15.28
- Ownership
- Direct
Stephen Davis - CEO, Director at ACADIA PHARMACEUTICALS INC
Issuer-level insider activity
- Role
- CEO, Director
- Issuer ticker
- ACAD on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Stephen Davis since 06 Oct 2025
Reported holdings for Stephen Davis in ACADIA PHARMACEUTICALS INC
Form 4 holding
CEO, Director
ACADIA PHARMACEUTICALS INC
- Security class
- Restricted Stock Units
- Shares / value
- 67,173
- Estimated value
- $1,200,382
- Report date
- 01 May 2024
- Price
- $17.87
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
CEO, Director
ACADIA PHARMACEUTICALS INC
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 286,451
- Estimated value
- Report date
- 25 Mar 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Stephen Davis in ACADIA PHARMACEUTICALS INC
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.